undefined (GRTS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | n/a |
Market Cap | 3.80M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.09 |
PE Ratio (ttm) | -0.03 |
Forward PE | n/a |
Analyst | Buy |
Ask | n/a |
Volume | 55,246,959 |
Avg. Volume (20D) | 17,430,328 |
Open | 0.04 |
Previous Close | 0.03 |
Day's Range | 0.03 - 0.04 |
52-Week Range | 0.01 - 3.17 |
Beta | undefined |
About GRTS
A detailed description of the company is not yet available....
Analyst Forecast
According to 4 analyst ratings, the average rating for GRTS stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
News
3 months ago · businesswire.com
Gritstone bio Takes Action to Preserve Value and Strengthen Capital StructureEMERYVILLE, Calif.--(BUSINESS WIRE)--Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a clinical-stage biotechnology company working to develop the world's most potent vaccines, toda...
7 months ago · businesswire.com
Gritstone bio, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the GRTS Class ActionSAN DIEGO--(BUSINESS WIRE)---- $GRTS #GRTS--Robbins LLP is Investigating Allegations that Gritstone bio, Inc. (GRTS) Misled Investors Regarding the Initiation of its Phase 2b CORAL Study.